Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 207777

Expand all

APREPITANT (APREPITANT)
40MG
Marketing Status: Prescription
Active Ingredient: APREPITANT
Proprietary Name: APREPITANT
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 40MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A207777
Product Number: 001
Approval Date: Oct 12, 2017
Applicant Holder Full Name: GLENMARK PHARMACEUTICALS SA SWITZERLAND
Marketing Status:  Prescription
Patent and Exclusivity Information
APREPITANT (APREPITANT)
80MG
Marketing Status: Prescription
Active Ingredient: APREPITANT
Proprietary Name: APREPITANT
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 80MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A207777
Product Number: 002
Approval Date: Oct 12, 2017
Applicant Holder Full Name: GLENMARK PHARMACEUTICALS SA SWITZERLAND
Marketing Status:  Prescription
Patent and Exclusivity Information
APREPITANT (APREPITANT)
125MG
Marketing Status: Prescription
Active Ingredient: APREPITANT
Proprietary Name: APREPITANT
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 125MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A207777
Product Number: 003
Approval Date: Oct 12, 2017
Applicant Holder Full Name: GLENMARK PHARMACEUTICALS SA SWITZERLAND
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English